Conference Coverage

ACR: A reminder about ADHD-stimulant vasculopathy


 

AT THE ACR ANNUAL MEETING

References

SAN FRANCISCO – Forty-seven children referred to Children’s Hospital of Georgia’s rheumatology clinic in Augusta for work-up of autoimmune vasculopathy had vasculopathy symptoms triggered by their ADHD stimulants.

They had been referred by primary care providers who told families that their children probably had an autoimmune disease; the families were relieved to find out that they did not, according to Dr. Rita Jerath, a pediatric rheumatologist in the department of rheumatology, Medical College of Georgia, Augusta.

Dr. Rita Jerath

Dr. Rita Jerath

The findings show that psychostimulant-induced peripheral vasculopathy, a known side effect included in the labeling of drugs such as methylphenidate (Ritalin or Concerta), dexmethylphenidate (Focalin), and amphetamine/dextroamphetamine (Adderall), is underrecognized in the medical community, leading to needless anxiety and unnecessary medical expenses, she noted.

Although uncommon, “there is a strong association between the use of psychostimulants and peripheral vasculopathy symptoms. Our study demonstrates the need of making prescribing physicians aware of this significant side effect so they may educate the families and also elucidate occurrence of new vascular symptoms [in] this patient population,” noted Dr. Jerath.

“A lot of rheumatologists will recognize this, but we want to get this message across to primary care physicians and families,” she added.

She had several tips for recognizing the problem. Otherwise well children seem to have Raynaud’s disease, “but their signs and symptoms are different,” she said. The color change is more extensive, on the tops of hands and feet, and more dusky and cyanotic. Hands and feet can be cold, numb, and painful, but the condition doesn’t change with cold or stress, as in Raynaud’s. Children can be positive for antinuclear antibodies, as several were in the study, Dr. Jerath said.

Children are usually on their psychostimulants from a few months or few years before an attack, and attacks seem to be triggered by a change in dose or drug.

The symptoms often improve with a drug holiday, for instance during vacation.

Although families are glad to learn their children don’t have an autoimmune disease, they are often reluctant to discontinue the stimulants. “A lot of times, the question is, ‘What else is available?’ There are a few medications that are not psychostimulants – Straterra [atomoxetine] is one – but usually physicians find they are not as helpful,” Dr. Jerath said.

The investigators had no disclosures.

aotto@frontlinemedcom.com

Recommended Reading

ED visits for tramadol misuse more than double over 5 years
MDedge Rheumatology
MDD tied to lower bone mineral density in men
MDedge Rheumatology
NSAID monotherapy as effective as combinations for low back pain
MDedge Rheumatology
Alcohol, marijuana use common in youth with chronic disease
MDedge Rheumatology
VIDEO: Use fiduciary duty to set pain medication boundaries
MDedge Rheumatology
Prescription opioid overdoses targeted in new CDC program
MDedge Rheumatology
Large study identifies psoriasis as an independent risk factor for major depression
MDedge Rheumatology
Opioid abuse more prevalent in females with major depression
MDedge Rheumatology
EADV: Spotlight on alexithymia in psoriasis
MDedge Rheumatology
Stroke risk rose in autoimmune disease patients after herpes zoster
MDedge Rheumatology